Related Experiment Video
Updated: Jan 25, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome
Maria Apellaniz-Ruiz1, Maria Segni1, Matthias Kettwig1
1From the Departments of Human Genetics (M.A.-R., M.K.W., W.D.F.), Pharmacology (D.P.), Oncology (M.R.F., W.D.F.), and Biochemistry (M.R.F.), and the Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital (M.A.-R., D.P., N.S., M.K.W., M.R.F., W.D.F.), McGill University, the Department of Pathology, Montreal Children's Hospital (V.-H.N.), the Department of Radiology (K.M.), and the Cancer Research Program, Research Institute (W.D.F.), McGill University Health Centre, and the Department of Pathology, Centre Hospitalier Universitaire Sainte-Justine (D.B.-D.S.) - all in Montreal; the Department of Pediatrics, Endocrinology Unit, Sapienza University, Rome (M.S.), and Centro Diagnostico Italiano, Milan (S.Z.) - both in Italy; the Department of Pediatrics and Adolescent Medicine, Faculty of Medicine (M.K.), and the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine (J.M.), Georg-August University, Göttingen, the Department of Pediatric Surgery, St. Bernward Krankenhaus Hildesheim, Hildesheim (S.G.), and the Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm (R.W., C.L., R.S.) - all in Germany; and Minneapolis (J.R.P.).
Abstract:
Mesenchymal hamartoma of the liver (MHL) is a benign tumor affecting children that is characterized by a primitive myxoid stroma with cystically dilated bile ducts. Alterations involving chromosome 19q13 are a recurrent underlying cause of MHL; these alterations activate the chromosome 19 microRNA cluster (C19MC). Other cases remain unexplained. We describe two children with MHLs that harbored germline DICER1 pathogenic variants. Analysis of tumor tissue from one of the children revealed two DICER1 "hits." Mutations in DICER1 dysregulate microRNAs, mimicking the effect of the activation of C19MC. Our data suggest that MHL is a new phenotype of DICER1 syndrome. (Funded by the Canadian Institutes of Health Research and others.).
Insights
Mesenchymal hamartoma of the liver (MHL) in children can be caused by DICER1 gene mutations. These mutations mimic chromosome 19 alterations, suggesting MHL is a new phenotype of DICER1 syndrome.
Area of Science:
- Pediatric Oncology
- Molecular Genetics
- Developmental Biology
Background:
- Mesenchymal hamartoma of the liver (MHL) is a benign pediatric liver tumor.
- Recurrent chromosomal alterations at 19q13, activating the C19MC microRNA cluster, are known causes of MHL.
- Some MHL cases lack these known genetic alterations.
Observation:
- Two pediatric MHL cases with germline DICER1 pathogenic variants were identified.
- Tumor tissue analysis in one case revealed biallelic DICER1 inactivation ('two hits').
Findings:
- DICER1 mutations dysregulate microRNA processing and biogenesis.
- This dysregulation mimics the molecular effects of C19MC activation seen in other MHL cases.
- The findings link DICER1 mutations to a distinct molecular pathway in MHL pathogenesis.
Implications:
- MHL may represent a novel clinical phenotype within the spectrum of DICER1-related disorders.
- This discovery expands the understanding of genetic causes for pediatric liver tumors.
- Identifying DICER1 as a causative gene opens avenues for potential targeted therapies and improved diagnostics.
More Related Videos
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
09:06Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Related Concept Videos
Mesenchymal Stem Cells
Nephrotic Syndrome I : Introduction
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Acute Coronary Syndrome I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...